Progress in Neuro-Psychopharmacology and Biological Psychiatry
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.2 | Q1 | 79.7% | 1.502 | Q1 | 92.0% |
| 2024 | 3.9 | Q1 | 81.3% | 1.768 | Q1 | 94.2% |
| 2023 | 5.3 | Q1 | 89.3% | 1.652 | Q1 | 93.8% |
| 2022 | 5.6 | Q1 | 83.5% | 1.543 | Q1 | 93.3% |
| 2021 | 5.2 | Q2 | 77.7% | 1.370 | Q1 | 91.9% |
| 2020 | — | — | 1.716 | Q1 | 94.1% | |
| 2019 | — | — | 1.714 | Q1 | 94.2% | |
| 2018 | — | — | 1.484 | Q1 | 91.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0278-5846
ISSN
1878-4216
country
UScoverage
1982-2026